Cannabis Bioscience International Holdings, Inc. (CBIH)

0.0007 +0.0000 (+7.69%) As of 12:17PM EDT. Market open.

Cannabis Bioscience International Holdings, Inc.

6201 Bonhomme Road
Suite 466S
Houston, TX 91789
United States
832 606 7500
https://www.chnc-hdh.com

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Dante Picazo	CEO, Chief Accounting Officer & Director	22.5k	N/A	1957
Mr. Henry Donald Levinski	VP, Treasurer & Director	24k	N/A	1953
Dr. Jose A. Torres	National Medical Director, Secretary & Director	N/A	N/A	1960

Amounts are as of 31 December 2021, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

China Infrastructure Construction Corp. provides educational systems that focuses on medical cannabis in the United States and Latin America, and worldwide through online education. The company offers services in the therapeutic areas of clinical trials; and relating to sleep disorders, including resulting infertility, through its fertility and sleep center in Houston, Texas. It also offers education, consulting, digital publishing, marketing, and franchising related to medical cannabis through its Pharmacology University. The company was founded in 2003 and is headquartered in Houston, Texas.

Corporate governance

Cannabis Bioscience International Holdings, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.